Vancomycin
- Generic Name
- Vancomycin
- Brand Names
- Firvanq, Vancocin
- Drug Type
- Small Molecule
- Chemical Formula
- C66H75Cl2N9O24
- CAS Number
- 1404-90-6
- Unique Ingredient Identifier
- 6Q205EH1VU
- Background
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
...
- Indication
Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections. Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of Clostridium difficile-associ...
- Associated Conditions
- Clostridium Difficile Associated Diarrhea (CDAD), Enterocolitis caused by Staphylococcus aureus, Infection caused by staphylococci, Severe Staphylococcal infection
- Associated Therapies
- -
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Thomas Jefferson University
- Target Recruit Count
- 4
- Registration Number
- NCT03685747
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Topical Antibiotics in Chronic Rhinosinusitis
- Conditions
- Interventions
- First Posted Date
- 2018-09-17
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 19
- Registration Number
- NCT03673956
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
- Conditions
- Interventions
- First Posted Date
- 2018-07-23
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Summit Therapeutics
- Target Recruit Count
- 759
- Registration Number
- NCT03595553
- Locations
- 🇧🇬
DCC1-Sliven Ltd., Sliven, Bulgaria
🇬🇷''Tzaneio'' General Hospital of Piraeus, Piraeus, Greece
🇭🇺Dr. Kenessey Albert Kórház Rendelőintézet, Tüdőgyógyászati Aktív Osztály, Balassagyarmat, Hungary
Vancomycin in the Target Site Treatment of Intracranial Infection
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2018-07-13
- Lead Sponsor
- Xijing Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT03585426
Responses to Rabies Vaccine in Adults With or Without Antibiotics
- Conditions
- Interventions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Emory University
- Target Recruit Count
- 37
- Registration Number
- NCT03557008
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸The Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States
Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT03546829
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement
- First Posted Date
- 2018-04-24
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 24
- Registration Number
- NCT03506347
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease
- Conditions
- Interventions
- First Posted Date
- 2018-03-26
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Children's Hospital of Philadelphia
- Target Recruit Count
- 10
- Registration Number
- NCT03476317
- Locations
- 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy
- Conditions
- Interventions
- First Posted Date
- 2018-03-15
- Last Posted Date
- 2018-03-15
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 126
- Registration Number
- NCT03466645
- Locations
- 🇮🇷
Isfahan university of medical science., Isfahan, Iran, Islamic Republic of
Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- University of Wisconsin, Madison
- Target Recruit Count
- 77
- Registration Number
- NCT03462459
- Locations
- 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸University of Wisconsin-Madison, Madison, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.